Cytokinetics Inc. (CYTK) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CYTK. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 17,523,840 | $1.2B | DECREASED |
| BlackRock, Inc. | 16,548,011 | $1.1B | INCREASED |
| FMR LLC | 10,723,140 | $707M | DECREASED |
| WELLINGTON MANAGEMENT GROUP LLP | 8,009,489 | $528M | INCREASED |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,843,782 | $385M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Fady Ibraham Malik (EVP Research & Development) | EXERCISE | 3,500 | $27K | 2026-06-23 |
| Fady Ibraham Malik (EVP Research & Development) | SELL | 3,500 | $278K | 2026-06-23 |
| Robert I Blum (President & CEO) | SELL | 7,500 | $528K | 2026-06-15 |
| Fady Ibraham Malik (EVP Research & Development) | EXERCISE | 3,500 | $27K | 2026-06-09 |
| Fady Ibraham Malik (EVP Research & Development) | SELL | 3,500 | $238K | 2026-06-09 |
Full institutional holdings, insider history, and congressional trades for Cytokinetics Inc. on SentiSense.